🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

12554+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 12554 recruiting trials

Phase 1RecruitingNCT05685173

A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas

👨‍⚕️ Clinical Trial Management, Regeneron Pharmaceuticals📍 20 sites📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT06685796

A Study of BEBT-209 in Combination With Chemotherapy for the Treatment of Advanced Triple-Negative Breast Cancer

👨‍⚕️ Quchang Ouyang, Phd, Hunan Cancer Hospital📍 2 sites📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT04478734

Trial of the Combined Use of Thiamine and Biotin in Patients With Huntington's Disease

👨‍⚕️ Pablo Mir Rivera, MD/PhD, Institute of Biomedicine of Seville (IBiS)📍 3 sites📅 Started Apr 2023View details ↗
Phase 1RecruitingNCT05682144

ISP-001: Sleeping Beauty Transposon-Engineered B Cells for MPS I

👨‍⚕️ Immusoft Clinical Development, Immusoft of CA, Inc.📍 2 sites📅 Started Apr 2023View details ↗
RecruitingNCT06191640

Sinus Disease in Young Children With Cystic Fibrosis

👨‍⚕️ Daniel M Beswick, MD, University of California, Los Angeles📍 6 sites📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05590455

Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis

👨‍⚕️ Nathalie DE CASTRO, MD, AP-HP, Hôpital Saint-Louis📍 3 sites📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05421325

Efficacy of QBKPN Site-Specific Immunomodulator in Improving Innate Immune Function & Reducing Respiratory Tract Infection in Older Adults

👨‍⚕️ Theodore Steiner, MD FRCPC, University of British Columbia📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT06318598

Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis

🏥 Istituto Auxologico Italiano📍 3 sites📅 Started Apr 2023View details ↗
Phase 1RecruitingNCT05363826

Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®

👨‍⚕️ William R Potter, MA, Photolitec LLC📍 1 site📅 Started Apr 2023View details ↗
Phase 3RecruitingNCT05555589

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

🏥 ReGenTree, LLC📍 36 sites📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05286788

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

👨‍⚕️ Holly Lindsay, MD, Children's Hospital Colorado📍 10 sites📅 Started Apr 2023View details ↗
Phase 1RecruitingNCT05544019

Study of SGR-1505 in Mature B-Cell Neoplasms

👨‍⚕️ Frank G Basile, M.D., Schrodinger Inc.📍 36 sites📅 Started Apr 2023View details ↗
Phase 3RecruitingNCT05654922

Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant

👨‍⚕️ Tim Whelan, MD, Medical University of South Carolina📍 20 sites📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05551793

Regeneron AA Multicenter (Dupilumab)

👨‍⚕️ Emma Guttman-Yassky, MD, PhD, Icahn School of Medicine at Mount Sinai📍 3 sites📅 Started Apr 2023View details ↗
Phase 2RecruitingNCT05640271

Tocilizumab for Acute Chest Syndrome

👨‍⚕️ Austin Wesevich, MD, University of Chicago📍 1 site📅 Started Apr 2023View details ↗
Phase 3RecruitingNCT05726786

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial)

🏥 Centre Hospitalier Universitaire Vaudois📍 4 sites📅 Started Apr 2023View details ↗
Phase 3RecruitingNCT05754450

An Extension Study Assessing the Safety and Efficacy of AVTX-803 in Subjects with Leukocyte Adhesion Deficiency Type II

👨‍⚕️ David Deyle, Mayo Clinic📍 1 site📅 Started Apr 2023View details ↗
NARecruitingNCT06053671

Mos-FED (Mosaicism in Focal Epilepsy Cortical Dysplasia Tissue)

🏥 King's College Hospital NHS Trust📍 1 site📅 Started Apr 2023View details ↗
RecruitingNCT05746182

Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms

👨‍⚕️ Emily Bergsland, MD, University of California, San Francisco📍 3 sites📅 Started Apr 2023View details ↗
NARecruitingNCT05641142

Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia

👨‍⚕️ Vincent GROBOST, University Hospital, Clermont-Ferrand📍 18 sites📅 Started Apr 2023View details ↗
← PreviousPage 416 of 628Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →